Aspirin and long-Term risk of heart failure in patients with high atherosclerotic risk

20 May 2023 (09:00 - 10:08)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Associate Professor Wanwarang Wongcharoen

Chiang Mai University, Chiang Mai (Thailand)

6 More presentations in this session

Presentation thumbnail

Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure

Doctor M. Davies (The Woodlands, US)

Abstract Slides

Presentation thumbnail

Utility of a heart failure treatment score (quad score) in predicting early outcomes in patients with heart failure and a reduced ejection fraction

Doctor B. Li (Basildon, GB)

Abstract Slides

Presentation thumbnail

Reverse cardiac remodeling effects of sacubitril/valsartan in adults with congenital heart disease

Doctor A. Ferreira (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.

Doctor R. Rascon Sabido (Veracruz, MX)

Abstract Slides

Presentation thumbnail

Prevalence of sodium glucose co-transporter 2 inhibitor related erythrocytosis (polycythaemia) in real world heart failure patients: a warning for the daily clinical practice

Mr E. Bruwiere ('s-Hertogenbosch, NL)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy 2

The Event

Event poster

Heart Failure 2023

20 May 2023 09:00 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources